Featured

As we wrap up 2024, it’s the perfect time to look back at a year filled with exciting advancements, initiatives and milestones. From groundbreaking studies

MAC Clinical Research is proud to announce the successful completion of the single ascending dose (SAD) phase of the first-in-human (FIH) clinical trial for KP405,

At MAC, patients and volunteers are more than participants – they are partners in everything we do. Their insights, experiences, and willingness to engage in

We are pleased to share a recent publication in conjunction with the UK Health Security Agency (UKHSA) and insights from MAC Clinical Research Statisticians Ellie

MAC Clinical Research’s Manchester site is an MHRA audited and accredited Phase I centre located within and supported by the Manchester University Foundation Trust, specialising

As well as working towards being a more sustainable company, there is a big drive for us to pass this ethos through our supply chain,

MAC Clinical Research and Kariya Pharmaceuticals are pleased to share the successful dosing of the first cohort in a phase 1 first-in-human (FIH) clinical trial

MAC Clinical Research is pleased to announce that we have joined the United Nations Global Compact initiative — a voluntary leadership platform for the development,

Clinical trials are a costly business, but with trial quality being so critical to patient safety and data integrity, getting it right is key. So